(Q74413874)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9531927%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

review article

1 reference

title

Menopause and hormone replacement therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9531927%20AND%20SRC:MED&resulttype=core&format=json

Hormone Replacement Therapy

10 November 2019

main subject

1 reference

S R Johnson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9531927%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 March 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9531927%20AND%20SRC:MED&resulttype=core&format=json

Medical Clinics of North America

10 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9531927%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

82

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9531927%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9531927%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

297-320

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9531927%20AND%20SRC:MED&resulttype=core&format=json

Hormone replacement and breast cancer. A remaining controversy?

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Safety of hormone replacement therapy (HRT) in systemic lupus erythematosus (SLE)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

The changes before 'the change'.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Clinical and biologic prognostic factors in breast cancer diagnosed during postmenopausal hormone replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Prevalence and determinants of estrogen replacement therapy in elderly women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Multiple coronary heart disease risk factors are associated with menopause and influenced by substitutive hormonal therapy in a cohort of French women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Hormone replacement therapy in a risk-benefit perspective.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Risk of venous thromboembolism in users of hormone replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Esophagitis associated with the use of alendronate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Prior and current health characteristics of postmenopausal estrogen replacement therapy users compared with nonusers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Superior compliance and efficacy of continuous combined oral estrogen-progestogen replacement therapy in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

The effect of postmenopausal estrogen therapy on bone density in elderly women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

The influence of female hormones on malignant melanoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Effects of estrogen and progestin on aortic size and compliance in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Hormone therapy to prevent disease and prolong life in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

The menopause: health implications and clinical management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Prospective study of exogenous hormones and risk of pulmonary embolism in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Are women using postmenopausal estrogens? A community survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

The clinical decision regarding hormone replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Routine endocrine screening for patients with karyotypically normal spontaneous premature ovarian failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Effects of estrogens on lipoprotein metabolism and cardiovascular disease in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Oral contraceptives and non-contraceptive oestrogens in the risk of gallstone disease requiring surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Medroxyprogesterone attenuates estrogen-mediated inhibition of neointima formation after balloon injury of the rat carotid artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

The primary prevention of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Nonlipid primary and secondary prevention strategies for coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Prior to use of estrogen replacement therapy, are users healthier than nonusers?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Influence of the perimenopause on cardiovascular risk factors and symptoms of middle-aged healthy women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

The normal menopause transition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

The treatment-seeking woman at menopause

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Clinical trial of the estradiol vaginal ring in the U.S.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Estrogen replacement therapy and stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy--long-term follow-up of a Swedish cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Coronary heart disease and estrogen replacement therapy. Can compliance bias explain the results of observational studies?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Affective changes with estrogen and androgen replacement theraphy in surgically menopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

The Impact of Different Doses of Estrogen and Progestin on Mood and Sexual Behavior in Postmenopausal Women*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Hormones, mood, and cognitive functioning in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Androgen enhances sexual motivation in females: a prospective, crossover study of sex steroid administration in the surgical menopause

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Effect of bone density information on decisions about hormone replacement therapy: a randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Coronary arteriography in estrogen-treated postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Estrogen, progesterone, and testosterone: can they be used to treat autoimmune diseases?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Probability of menopause with increasing duration of amenorrhea in middle-aged women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopause

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Hormone replacement therapy in previously treated breast cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

Hormone replacement therapy and breast cancer mortality in Swedish women: results after adjustment for 'healthy drug-user' effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970608-8

10.1016/S0025-7125(05)70608-8

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9531927%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference